Kuki Ichiro, Kawawaki Hisashi, Okazaki Shin, Inoue Takeshi, Nukui Megumi, Tomiwa Kiyotaka, Amou Kiyoko, Togawa Masao, Shiomi Masashi
Division of Pediatric Neurology, Osaka City General Hospital, Osaka.
No To Hattatsu. 2012 Jan;44(1):5-12.
This study examined the usefulness of 123I-iomazenil SPECT (IMZ-SPECT), a type of brain scintigram that focuses on the central benzodiazepine receptor in order to determine its distribution and the function of inhibitory neurons. IMZ-SPECT has been used for the detection of epileptogenic foci, especially when surgical intervention is considered. Interictal study by IMZ-SPECT is widely available at numerous institutions and its usefulness has been confirmed in patients with not only focal cortical dysplasia and hippocampal sclerosis, but also tuberous sclerosis and neuronal migration disorders, even when magnetic resonance image fails to demonstrate any abnormal findings. When interpreting scintigrams, the developmental dynamic change of the central benzodiazepine receptor in childhood and the duration of the benzodiazepine exposure period should be taken into consideration. It is expected that IMZ-SPECT will be used in various neurological disorders other than epilepsy in the future allow medical services to be provided based on findings in the inhibitory synaptic system obtained with IMZ-SPECT.
本研究检测了123I-碘美西泮单光子发射计算机断层扫描(IMZ-SPECT)的效用,这是一种聚焦于中枢苯二氮䓬受体的脑闪烁扫描,用于确定其分布以及抑制性神经元的功能。IMZ-SPECT已用于检测致痫灶,尤其是在考虑手术干预时。IMZ-SPECT的发作间期研究在众多机构广泛开展,其效用不仅在局灶性皮质发育不良和海马硬化患者中得到证实,在结节性硬化症和神经元迁移障碍患者中也得到证实,即使磁共振成像未显示任何异常发现。在解读闪烁扫描图时,应考虑儿童期中枢苯二氮䓬受体的发育动态变化以及苯二氮䓬暴露期的时长。预计未来IMZ-SPECT将用于癫痫以外的各种神经系统疾病,以便根据IMZ-SPECT在抑制性突触系统中获得的结果提供医疗服务。